SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-023958
Filing Date
2021-02-16
Accepted
2021-02-16 16:09:56
Documents
2
Group Members
JEREMY C. GREEN

Document Format Files

Seq Description Document Type Size
1 SC 13G tm215825d26_sc13g.htm SC 13G 71213
2 EXHIBIT 99.1 tm215825d26_ex99-1.htm EX-99.1 4693
  Complete submission text file 0001104659-21-023958.txt   77669
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91478 | Film No.: 21638356
SIC: 2834 Pharmaceutical Preparations